Double-blind, placebo-controlled study on the effect of the aldosterone receptor antagonist spironolactone in patients who have persistent proteinuria and are on long-term angiotensin-converting enzyme inhibitor therapy, with or without an angiotens
(Q80796915)
scientific article published on 01 February 2006
scientific article published on 01 February 2006
Language:
other details
| description | scientific article published on 01 February 2006 |
External Links
| (P356) |
10.2215/CJN.01040905
|
| (P698) |
17699214
|